RBSH (Rebus Hldgs) EBITDA Margin %: 0.00% (As of Jun. 2023)

What is Rebus Hldgs EBITDA Margin %?

Rebus Hldgs RBSH EBITDA Margin % is 0.00% as of Jun. 2023.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Rebus Hldgs's EBITDA for the three months ended in Jun. 2023 was $0.05 Mil. Rebus Hldgs's Revenue for the three months ended in Jun. 2023 was $0.00 Mil. Therefore, Rebus Hldgs's EBITDA margin for the quarter that ended in Jun. 2023 was 0.00%.

Rebus Hldgs (OTCPK:RBSH) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Rebus Hldgs EBITDA Margin % Related Terms

Rebus Hldgs EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Rebus Hldgs's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rebus Hldgs EBITDA Margin % Chart

Rebus Hldgs Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBITDA Margin %

Get a 7-Day Free Trial

0.00

Rebus Hldgs Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
EBITDA Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

RBSH vs KRBP, CNBX, EVFM: EBITDA Margin % Comparison

For the Biotechnology subindustry, Rebus Hldgs's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rebus Hldgs EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rebus Hldgs's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Rebus Hldgs's EBITDA Margin % falls into.

Save Embed

Rebus Hldgs EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Rebus Hldgs's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-0.951	/	0
	=	%

Rebus Hldgs's EBITDA Margin % for the quarter that ended in Jun. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	0.047	/	0
	=	%

Frequently Asked Questions Learn more about EBITDA Margin % →

What does a EBITDA Margin % of 0.00% mean?

Rebus Hldgs (RBSH) has a EBITDA Margin % of 0.00% as of Jun. 2023. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Rebus Hldgs and its competitors.

Is Rebus Hldgs' EBITDA Margin % too high?

Rebus Hldgs' current EBITDA Margin % is 0.00%.

How does Rebus Hldgs' EBITDA Margin % compare to KRBP and CNBX?

Rebus Hldgs' EBITDA Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBITDA Margin % for a Biotechnology company?

A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBITDA Margin % mean?

A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Rebus Hldgs and its competitors. Rebus Hldgs's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Rebus Hldgs stock overvalued right now?

Rebus Hldgs (RBSH) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBITDA Margin % calculated?

EBITDA Margin % is calculated from a company's financial statements. For Rebus Hldgs (RBSH), the current EBITDA Margin % is 0.00% as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rebus Hldgs Business Description

Industry Healthcare Biotechnology

Comparable Companies KRBP CNBX EVFM MYMX HGEN INFIQ RSPI PPCB CALA QBIO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX

Address 2629 Townsgate Road, Suite 215, Westlake Village, CA, USA, 91361

Website http://www.rebus-corp.com

Rebus Hldgs Inc is an early-stage, pre-revenue, pharmaceutical company that is focused on the development of prodrug cancer therapeutics for the treatment of disease. The company along with its subsidiaries is engaged in the production of small-molecule adenosine receptor modulators. Adenosine is an extracellular signaling molecule that regulates multiple aspects of tissue function and specifically plays a role in immunity and inflammation.